Mammoplasty
U.S. FDA Approves New MENTOR MemoryGel BOOST Breast Implant
MammoplastyU.S. FDA Approves New MENTOR MemoryGel BOOST Breast ImplantU.S. FDA Approves New MENTOR MemoryGel BOOST Breast Implant
Mentor Worldwide LLC, the number one global brand in breast aesthetics, and part of the Johnson & Johnson Medical Devices Companies** today announced that the U.S. Food and Drug Administration (FDA) approved the MENTOR® MemoryGel BOOST™ Breast Implant for breast augmentation in women at least 22 years old, and for women of all ages undergoing breast reconstruction. This product will be commercially available for surgeons in the United States in early 2022.
Surgical Innovation Associates Reports 1st US Patient
MammoplastySurgical Innovation Associates Reports 1st US Patient Implanted in Pivotal IDE Study of DuraSorb Monofilament Mesh Use in Prosthetic Breast ReconstructionSurgical Innovation Associates Reports 1st US Patient Implanted in Pivotal IDE Study of DuraSorb Monofilament Mesh Use in Prosthetic Breast Reconstruction
Subscribe to receive the latest in aesthetic medicine.
Get breaking developments, expert product comparisons, clinical roundtables, and practice strategies—all for free.